These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8379045)

  • 21. [Lansoprazole--profile of a new proton pump inhibitor].
    Seifert E
    Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omeprazole: a new approach to gastric acid suppression.
    Buhl K; Clearfield HR
    Am Fam Physician; 1990 Apr; 41(4):1225-7. PubMed ID: 2321497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The gastrin hypothesis. Implications for antisecretory drug selection.
    Karnes WE; Walsh JH
    J Clin Gastroenterol; 1990; 12 Suppl 2():S7-12. PubMed ID: 2246496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Substituted benzimidazoles--a new dimension in ulcer therapy?].
    Fimmel CJ; Blum AL
    Wien Klin Wochenschr; 1984 Feb; 96(4):149-53. PubMed ID: 6324498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Omeprazole. Its pharmacology and therapeutic efficacy].
    Protzer U; Holtermüller KH
    Dtsch Med Wochenschr; 1993 Feb; 118(7):230-9. PubMed ID: 8440164
    [No Abstract]   [Full Text] [Related]  

  • 26. [Omeprazole].
    Isal JP
    Gastroenterol Clin Biol; 1987 Nov; 11(11):768-80. PubMed ID: 3322924
    [No Abstract]   [Full Text] [Related]  

  • 27. Neuroendocrine cell hyperplasia and neuroendocrine carcinoma of the rodent fundic stomach.
    Poynter D; Selway SA
    Mutat Res; 1991 Jun; 248(2):303-19. PubMed ID: 2046687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omeprazole: a comprehensive review.
    Massoomi F; Savage J; Destache CJ
    Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemolytic anemia associated with the use of omeprazole.
    Marks DR; Joy JV; Bonheim NA
    Am J Gastroenterol; 1991 Feb; 86(2):217-8. PubMed ID: 1992636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Omeprazole and peptic ulcer. Profile of a new active agent].
    Müller P; Dammann HG; Simon B
    Fortschr Med; 1987 Jan; 105(2):35-8. PubMed ID: 3557254
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of omeprazole in healing and prevention of reflux disease.
    Klinkenberg-Knol EC
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():27-30. PubMed ID: 1577392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of omeprazole in patients with Zollinger-Ellison syndrome.
    Frucht H; Maton PN; Jensen RT
    Dig Dis Sci; 1991 Apr; 36(4):394-404. PubMed ID: 2007355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Omeprazole long-term therapy: how great is the risk of developing a carcinoid tumor?].
    Koop H
    Z Gastroenterol; 1988 Dec; 26(12):769-71. PubMed ID: 3149827
    [No Abstract]   [Full Text] [Related]  

  • 34. [Omeprazole--a drug-blocking proton pump of the parietal cells of the stomach].
    Sosnowski M
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1469-72. PubMed ID: 3008128
    [No Abstract]   [Full Text] [Related]  

  • 35. Development of sustained achlorhydria in a patient with the Zollinger-Ellison syndrome treated with omeprazole.
    Griffith JL; Cummings OW; Hirschowitz BI
    Gastroenterology; 1991 Jul; 101(1):242-6. PubMed ID: 1796940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastric carcinoid tumours in patients with Zollinger-Ellison syndrome on long-term omeprazole.
    Goldfain D; le Bodic MF; Lavergne A; Galian A; Modigliani R
    Lancet; 1989 Apr; 1(8641):776-7. PubMed ID: 2564577
    [No Abstract]   [Full Text] [Related]  

  • 37. The clinical safety of omeprazole.
    Sölvell L
    Digestion; 1990; 47 Suppl 1():59-63; discussion 76. PubMed ID: 2093017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Reduction of gastric acid secretion: pathophysiologic and clinically relevant sequelae].
    Koop H; Eissele R
    Z Gastroenterol; 1991 Nov; 29(11):613-7. PubMed ID: 1685286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Qualitative studies of gastric endocrine cells in patients treated long-term with omeprazole.
    Solcia E; Rindi G; Havu N; Elm G
    Scand J Gastroenterol Suppl; 1989; 166():129-37; discussion 138-9. PubMed ID: 2513643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined use of omeprazole and a novel antioxidative cytoprotectant for the treatment of peptic ulcer. Facilitation of ulcer healing in experimental animals.
    Kim JM; Choi SM; Kim DH; Oh TY; Ahn BO; Kwon JW; Kim WB
    Arzneimittelforschung; 2005; 55(7):387-93. PubMed ID: 16080278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.